IT does seem as if the equity research world is going through an existential crisis. A plethora of issues are impacting the industry. Regulatory and technology-driven changes are among them.
The industry faces new research payment unbundling rules under the second Markets in Financial Instruments Directive (MiFID II).
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
